Responses
Clinical and epidemiological research
Extended report
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab
Compose a Response to This Article
Other responses
No responses have been published for this article.